Antabio's Grant - VI Round

Antabio raised a round of funding on May 12, 2015. Investors include Wellcome Trust.

Antabio is a biopharmaceutical company developing novel antibacterial resistance-breakers to treat drug-resistant infections in areas of highest unmet medical need.…

Articles about Antabio's Grant - VI Round: